Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
Used against a variety of tumours, doxorubicin (DOX), causes multiple side-effects in patients, especially in high doses required to control tumour growth. A drug delivery system (DDS) was developed to deliver DOX. Through DOX encapsulation into chitosan DDS, novel DOX microparticles (DMPs) were for...
| Main Authors: | Tan, M., Choong, P., Dass, Crispin |
|---|---|
| Format: | Journal Article |
| Published: |
Trans Tech Publications, Switzerland
2010
|
| Online Access: | http://hdl.handle.net/20.500.11937/26348 |
Similar Items
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)
by: Wong, J., et al.
Published: (2016)
Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)
by: Manchun, S., et al.
Published: (2015)
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015)
by: Friedhuber, A., et al.
Published: (2015)
Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)
by: Armstrong, J., et al.
Published: (2015)
Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)
by: Manchun, S., et al.
Published: (2014)
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011)
by: Broadhead, M., et al.
Published: (2011)
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)
by: Tan, M., et al.
Published: (2013)
Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin
by: Manchun, S., et al.
Published: (2016)
by: Manchun, S., et al.
Published: (2016)
Systemic delivery of free chitosan accelerates femur fracture healing in rats
by: Shao, P., et al.
Published: (2018)
by: Shao, P., et al.
Published: (2018)
Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
by: Baxter-Holland, M., et al.
Published: (2018)
by: Baxter-Holland, M., et al.
Published: (2018)
Thiolated pectin–doxorubicin conjugates: Synthesis, characterization and anticancer activity studies
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
Methods for co-culturing tumour and endothelial cells: systems and their applications
by: Moorst, M., et al.
Published: (2011)
by: Moorst, M., et al.
Published: (2011)
Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Targeted delivery of doxorubicin-loaded cockle shell-derived CaCO3 aragonite nanoparticles on dog bearing tumour
by: Danmaigoro, Abubakar, et al.
Published: (2018)
by: Danmaigoro, Abubakar, et al.
Published: (2018)
Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)
by: Tacar, O., et al.
Published: (2015)
Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)
by: Cheewatanakornkool, K., et al.
Published: (2018)
Characterization and in vitro release studies of oral microbeads containing thiolated pectin-doxorubicin conjugates for colorectal cancer treatment
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
Biodegradable drug delivery systems for cancer therapy
by: Wong, T., et al.
Published: (2017)
by: Wong, T., et al.
Published: (2017)
Dz13: c-Jun Downregulation and Tumour Cell Death
by: Elahy, M., et al.
Published: (2011)
by: Elahy, M., et al.
Published: (2011)
Development and molecular characterization of doxorubicin-resistant canine mammary gland tumour cells
by: Sahabi, Kabiru, et al.
Published: (2022)
by: Sahabi, Kabiru, et al.
Published: (2022)
Drug delivery in cancer using liposomes
by: Dass, Crispin
Published: (2008)
by: Dass, Crispin
Published: (2008)
Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy
by: Tomek, M., et al.
Published: (2012)
by: Tomek, M., et al.
Published: (2012)
Treatment of lung cancer using nanoparticle drug delivery systems
by: Chandolu, V., et al.
Published: (2013)
by: Chandolu, V., et al.
Published: (2013)
Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy
by: Hallaj-Nezhadi, S., et al.
Published: (2010)
by: Hallaj-Nezhadi, S., et al.
Published: (2010)
In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
Role of vitamin D metabolism in cutaneous tumour formation and progression
by: Nemazannikova, N., et al.
Published: (2013)
by: Nemazannikova, N., et al.
Published: (2013)
Doxorubicin-loaded magnetic gold nanoshells for a combination therapy of hyperthermia and drug delivery
by: Mohammad, Faruq, et al.
Published: (2014)
by: Mohammad, Faruq, et al.
Published: (2014)
Reduction in tumour cell invasion by pigment epithelium-derived factor is mediated by membrane type-1 matrix metalloproteinase downregulation
by: Filiz, G., et al.
Published: (2012)
by: Filiz, G., et al.
Published: (2012)
The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation.
by: Wong, C., et al.
Published: (2017)
by: Wong, C., et al.
Published: (2017)
Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles
by: Lee, A., et al.
Published: (2011)
by: Lee, A., et al.
Published: (2011)
Development of cockleshell (Anadara granosa) derived CaCO3 nanoparticle for doxorubicin delivery
by: Danmaigoro, Abubakar, et al.
Published: (2017)
by: Danmaigoro, Abubakar, et al.
Published: (2017)
RECK in Osteosarcoma: A Novel Role in Tumour Vasculature and Inhibition of Tumorigenesis in an Orthotopic Mode
by: Clark, J., et al.
Published: (2011)
by: Clark, J., et al.
Published: (2011)
Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review
by: Elgadir, M.Abd, et al.
Published: (2015)
by: Elgadir, M.Abd, et al.
Published: (2015)
Barriers to liposomal gene delivery: From application site to the target
by: Saffari, M., et al.
Published: (2016)
by: Saffari, M., et al.
Published: (2016)
Drug delivery in a tumour cord model: a computational simulation
by: Hubbard, Matthew E., et al.
Published: (2017)
by: Hubbard, Matthew E., et al.
Published: (2017)
Development, characterization and anti-cancer activity of liposomal doxorubicin hydrochloride with palm oil / Bahareh Sabeti
by: Bahareh, Sabeti
Published: (2017)
by: Bahareh, Sabeti
Published: (2017)
Chitosan-Nanoparticles As A Drug Delivery System For 5-Fluorouracil
by: Suardi, Muslim
Published: (2003)
by: Suardi, Muslim
Published: (2003)
Similar Items
-
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013) -
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013) -
Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016) -
Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015) -
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours
by: Tan, M., et al.
Published: (2010)